 
    Two Sigma Ventures is an early-stage venture capital fund that invests in companies run by highly driven people.
Two Sigma Ventures is an early-stage venture capital fund based in New York City investing capital and expertise in entrepreneurs leveraging data and computing to create the future. In partnership with our parent company, Two Sigma Investments, we provide entrepreneurs access to a proprietary network of experts and startup resources to give them a competitive edge.
| 
                        Date
                        Company Name
                     | Round | Money Raised | Industry | Lead Investor | 
|---|---|---|---|---|
| 
                      Dec 21, 2022
                      
                            Enveda Biosciences | Series B | $55M | Biotechnology | — | 
| 
                      Nov 29, 2022
                      
                            Cajal Neuroscience | Series A | $96M | Biotechnology | — | 
| 
                      Jul 13, 2022
                      
                            Xilis | Series A | $19M | Biotechnology | — | 
| 
                      May 18, 2022
                      
                            Isabl Inc. | Seed | $3M | Biotechnology | Yes | 
| 
                      Apr 11, 2022
                      
                            Tive | Series B | $54M | Enterprise Software | — |